Crinetics Pharmaceuticals CRNX Proceeds from exercise of stock options and shares issued under Employee Stock Purchase Plan
Proceeds from exercise of stock options and shares issued under Employee Stock Purchase Plan at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept crnx:ProceedsFromStockOptionsExercisedAndSharesIssuedUnderEmployeeStockPurchasePlan.
The official record: Crinetics Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's proceeds from exercise of stock options and shares issued under employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's proceeds from exercise of stock options and shares issued under employee stock purchase plan?
- Crinetics Pharmaceuticals (CRNX) reported proceeds from exercise of stock options and shares issued under employee stock purchase plan of $10.15M in Q4 2025.
- How has Crinetics Pharmaceuticals's proceeds from exercise of stock options and shares issued under employee stock purchase plan changed year-over-year?
- Crinetics Pharmaceuticals's proceeds from exercise of stock options and shares issued under employee stock purchase plan decreased by 9.0% year-over-year, from $11.15M to $10.15M.
- What is the long-term trend for Crinetics Pharmaceuticals's proceeds from exercise of stock options and shares issued under employee stock purchase plan?
- Over 2 years (2023 to 2025), Crinetics Pharmaceuticals's proceeds from exercise of stock options and shares issued under employee stock purchase plan has grown at a 35.2% compound annual growth rate (CAGR), from $22.22M to $40.61M.
- What does proceeds from exercise of stock options and shares issued under employee stock purchase plan mean?
- This represents the cash inflows received from employees or directors exercising stock options or purchasing shares through employee stock purchase plans. It serves as a source of non-dilutive capital while reflecting the alignment of employee incentives with shareholder interests. Investors monitor this to assess the impact of equity-based compensation programs on the company's cash position.